Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma

Xiangyu Zhai; Wei Wang; Yunlong Ma; Yijia Zeng; Dandan Dou; Haoning Fan; Jianping Song; Xin Yu; Danqing Xin; Gang Du; Zhengchen Jiang; Hao Zhang; Xinlu Zhang; Bin Jin

doi:doi:10.18632/aging.103964

← Back

Research Paper Volume 12, Issue 23 pp 23761—23777

Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma

Figure 5. (A) Kaplan-Meier analysis of overall survival (OS) and disease-free survival (DFS) in 177 patients with CCA according to KIAA1199 staining. (B, C) Univariate and multivariate analyses of factors associated with survival and recurrence.